|
Canada-0-Insurance Azienda Directories
|
Azienda News:
- Meet Our Executive Leadership Team | Sanofi
Get to know the executive leaders at Sanofi who drive innovation, commitment, and success across our global healthcare endeavors
- Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson on Thursday, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from U S anti
- Sanofi ousts CEO Hudson, names Belén Garijo new CEO - CNBC
French drugmaker Sanofi ousted CEO Paul Hudson on Thursday appointed Belén Garijo, the head of German drugmaker Merck KGaA, as new chief executive
- Paul Hudson (businessman) - Wikipedia
Paul Hudson (born 14 October 1967) [2] is a British businessman, and the former chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales
- Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA . . .
Sanofi on Thursday announced the ouster of CEO Paul Hudson after a six-year tenure that included a major transformation of the French drugmaker and the rise of Dupixent into one of the world’s best-selling medicines
- Sanofi ousts Paul Hudson for Merck KGaA chief after bumpy ride
Sanofi has replaced its CEO Paul Hudson after a series of R D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M D , Ph D
- Sanofi says board has removed CEO Paul Hudson
French pharmaceutical giant Sanofi has removed Paul Hudson as chief executive, thanking him Thursday for "valuable contributions" but without giving any reason for his surprise exit
- Sanofi Shares Fall After CEO Change - WSJ
The change at the helm of the French company follows a string of clinical setbacks last year that put its shares under pressure and left investors and analysts wondering whether Sanofi would be
- Sanofi CEO Change: Paul Hudson Exits as Belén Garijo Named Next CEO
Paul Hudson LinkedIn Following Sanofi’s announcement that Hudson’s mandate would not be renewed The company subsequently appointed Belén Garijo as his successor Garijo has served since 2021 as CEO and Chair of the Executive Board of Merck KGaA
- Sanofi’s stunning CEO switch—Chutes Ladders
Belén Garijo, M D , Ph D Sanofi is replacing CEO Paul Hudson with Merck KGaA leader Belén Garijo, M D , Ph D , after a series of R D setbacks at the French pharma
|
|